Word

ACINO PHARMA - DELIVERING HEALTH

Status

Dead

Status Code

404

Status Date

Sunday, March 5, 2023

Serial Number

79130005

Registration Number

4479450

Registration Date

Tuesday, February 11, 2014

Mark Type

4000

Filing Date

Tuesday, March 5, 2013

Published for Opposition

Tuesday, November 26, 2013

Cancellation Date

Sunday, March 5, 2023

Trademark Owner History

Acino International AG - Original Registrant
Acino Holding AG - Owner At Publication
Acino Pharma AG - Original Applicant

Classifications

5 Pharmaceuticals for treating pain, infectious diseases, namely, respiratory infections, gastroenterological system infections, infections of the genitourinary system, infections of the mouth and teeth, namely, tooth abscess, eye infections, ear infections; pharmaceuticals for treating viral diseases, namely, herpes, hepatitis, acquired immune deficiency syndrome (AIDS); pharmaceuticals for treating neurological diseases, namely, Alzheimer's disease, Huntington's disease, cerebral palsy, encephalitis, epilepsy, migraine, insomnia; pharmaceuticals for treating the central nervous system, namely, infections of the central nervous system, brain diseases, motor disorders, diseases of the spinal cord; pharmaceuticals for treating psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, psychotic disorders; pharmaceuticals for use in oncology; pharmaceuticals for the treatment of cardiovascular diseases; pharmaceuticals for treating the respiratory system; pharmaceuticals for use in gastroenterology; pharmaceuticals for treating oral and dental diseases, namely, oral vaccine preparations; pharmaceutical preparations for use in ophthalmology; pharmaceuticals for treating inflammatory diseases, namely, inflammatory intestinal diseases, inflammatory diseases of the connective tissue; pharmaceuticals for treating immunological diseases, namely, autoimmune diseases, immune deficiency syndromes; pharmaceuticals for use in dermatology, namely, for treating dermatitis, skin pigmentation anomalies, sexually transmitted diseases; pharmaceuticals for treating the musculoskeletal system, namely, connective tissue diseases, bone diseases, diseases of the spinal column, back pain, fractures, sprains, cartilage lesions; dietetic substances for medical use, namely, nucleic acids, proteins, toxins, antibiotics, antiviral molecules, immunomodulators; plasters, materials for dressings for medical purposes; material for dental fillings and dental impressions; disinfectants, namely, all-purpose disinfectants, disinfectants for medical instruments and hand disinfectants for hygienic purposes

42 Scientific and technological services, namely, research services in the field of pharmacy, medicine and chemistry; scientific research consultancy, in particular in the field of pharmacy, medicine and chemistry; scientific consultancy in the field of pharmacology

Color is not claimed as a feature of the mark.
"PHARMA"

Trademark Events

Oct 2, 2023

Notification Of Effect Of Cancellation Of Intl Reg E-Mailed

Oct 2, 2023

Death Of International Registration

Mar 13, 2022

Total Invalidation Processed By The Ib

Feb 17, 2022

Total Invalidation Of Reg Ext Protection Sent To Ib

Feb 17, 2022

Invalidation Processed

Oct 26, 2021

Total Invalidation Of Reg Ext Protection Created

Feb 26, 2021

Cancelled Section 71

Feb 11, 2019

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Mar 16, 2017

Teas Change Of Correspondence Received

Jun 9, 2016

Change Of Name/Address Rec'd From Ib

Jul 8, 2015

Attorney/Dom.Rep.Revoked And/Or Appointed

Jul 8, 2015

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jul 24, 2014

Final Decision Transaction Processed By Ib

Jun 20, 2014

Final Disposition Notice Sent To Ib

Jun 20, 2014

Final Disposition Processed

May 11, 2014

Final Disposition Notice Created, To Be Sent To Ib

Feb 11, 2014

Registered-Principal Register

Dec 3, 2013

Notification Processed By Ib

Nov 26, 2013

Official Gazette Publication Confirmation E-Mailed

Nov 26, 2013

Published For Opposition

Nov 13, 2013

Notification Of Possible Opposition Sent To Ib

Nov 13, 2013

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Nov 6, 2013

Notification Of Notice Of Publication E-Mailed

Oct 23, 2013

Law Office Publication Review Completed

Oct 20, 2013

Approved For Pub - Principal Register

Oct 20, 2013

Examiner's Amendment Entered

Oct 20, 2013

Notification Of Examiners Amendment E-Mailed

Oct 20, 2013

Examiners Amendment E-Mailed

Oct 20, 2013

Examiners Amendment -Written

Oct 11, 2013

Teas/Email Correspondence Entered

Oct 11, 2013

Correspondence Received In Law Office

Oct 7, 2013

Assigned To Lie

Oct 5, 2013

Teas Request For Reconsideration Received

Sep 27, 2013

Notification Of Final Refusal Emailed

Sep 27, 2013

Final Refusal E-Mailed

Sep 27, 2013

Final Refusal Written

Sep 13, 2013

Change Of Owner Received From Ib

Sep 9, 2013

Teas/Email Correspondence Entered

Sep 8, 2013

Correspondence Received In Law Office

Sep 8, 2013

Teas Response To Office Action Received

Jul 22, 2013

Refusal Processed By Ib

Jun 28, 2013

Non-Final Action Mailed - Refusal Sent To Ib

Jun 28, 2013

Refusal Processed By Mpu

Jun 25, 2013

Non-Final Action (Ib Refusal) Prepared For Review

Jun 24, 2013

Non-Final Action Written

Jun 17, 2013

Assigned To Examiner

Jun 7, 2013

Application Filing Receipt Mailed

Jun 3, 2013

New Application Office Supplied Data Entered

May 31, 2013

Limitation From Original Application Entered

May 30, 2013

Sn Assigned For Sect 66a Appl From Ib